The Obesity Paradox in Type 2 Diabetes Mellitus: Relationship of Body Mass Index to Prognosis: A Cohort Study
Open accessThe DOI matches its Crossref record; 49 of the 49 references it cites were found in a registry or an index.
Abstract
BACKGROUND: Whether obesity is associated with a better prognosis in patients with type 2 diabetes mellitus is controversial. OBJECTIVE: To investigate the association between body weight and prognosis in a large cohort of patients with type 2 diabetes followed for a prolonged period. DESIGN: Prospective cohort. SETTING: National Health Service, England. PATIENTS: Patients with diabetes. MEASUREMENTS: The relationship between body mass index (BMI) and prognosis in patients with type 2 diabetes without known cardiovascular disease at baseline was investigated. Information on all-cause mortality and cardiovascular morbidity (such as the acute coronary syndrome, cerebrovascular accidents, and heart failure) was collected. Cox regression survival analysis, corrected for potential modifiers, including cardiovascular risk factors and comorbid conditions (such as cancer, chronic kidney disease, and lung disease), was done. RESULTS: 10,568 patients were followed for a median of 10.6 years (interquartile range, 7.8 to 13.4). Median age was 63 years (interquartile range, 55 to 71), and 54% of patients were men. Overweight or obese patients (BMI >25 kg/m²) had a higher rate of cardiac events (such as the acute coronary syndrome and heart failure) than those of normal weight (BMI, 18.5 to 24.9 kg/m²). However, being overweight (BMI, 25 to 29.9 kg/m²) was associated with a lower mortality risk, whereas obese patients (BMI >30 kg/m²) had a mortality risk similar to that of normal-weight persons. Patients with low body weight had the worst prognosis. LIMITATION: Data about cause of death were not available. CONCLUSION: In this cohort, patients with type 2 diabetes who were overweight or obese were more likely to be hospitalized for cardiovascular reasons. Being overweight was associated with a lower mortality risk, but being obese was not. PRIMARY FUNDING SOURCE: National Institute for Health Research and University of Hull.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Although obesity is a major risk factor for T2D, paradoxically overweight and obese patients have been reported to have had a lower mortality rate than normal-weight patients due to cardiovascular pathology associated with T2D and this phenomenon was termed “the obesity paradox”.134,135”
From A review of current trends with type 2 diabetes epidemiology, aetiology, pathogenesis, treatments and future perspectives (2021) · cites this paper as [134]
Citations
Cites
A Novel Paradigm for Heart Failure With Preserved Ejection Fraction
Paulus, W. J., & Tschöpe, C. (2013) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2013.02.092 · Cited by 3,564 · cited 1×
“Our study suggests that type 2 diabetes induced by the metabolic stress of obesity may fundamentally differ from that which develops in the absence of obesity (32, 33).”
BackgroundRandomized, Controlled Trials, Observational Studies, and the Hierarchy of Research Designs
Concato, J., Shah, N., & Horwitz, R. I. (2000) · New England Journal of Medicine · doi:10.1056/nejm200006223422507 · Cited by 3,563 · cited 1×
“long-term follow-up; include relevant confounding factors, such as comorbid conditions; not include patients who are underweight in the normal-weight group; use primary data (collected by the investigator for the purpose of the study); and use consistent data definitions, which might be best achieved in a single cente…”
MethodCardiovascular effects of intensive lifestyle intervention in type 2 diabetes
The Look AHEAD Research Group (2013) · New England Journal of Medicine · doi:10.1056/nejmoa1212914 · Cited by 2,908 · cited 1×
“However, the intervention had little effect on weight (36, 37).”
BackgroundBody-mass index and mortality among 1.46 million white adults
Berrington de Gonzalez, A., Hartge, P., Cerhan, J. R., Flint, A. J., Hannan, L., MacInnis, R. J., Moore, S. C., Tobias, G. S., Anton-Culver, H., Freeman, L. B., et al. (2010) · New England Journal of Medicine · doi:10.1056/nejmoa1000367 · Cited by 2,317
Overweight, Obesity, and Mortality in a Large Prospective Cohort of Persons 50 to 71 Years Old
Adams, K. F., Schatzkin, A., Harris, T. B., Kipnis, V., Mouw, T., Ballard-Barbash, R., Hollenbeck, A., & Leitzmann, M. F. (2006) · New England Journal of Medicine · doi:10.1056/nejmoa055643 · Cited by 2,116 · cited 1×
“The association between obesity and increased risk for cardiovascular disease (CVD) is well-established in the general population (5, 6).”
BackgroundWaist circumference and not body mass index explains obesity-related health risk
Janssen, I., Katzmarzyk, P. T., & Ross, R. (2004) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/79.3.379 · Cited by 2,013 · cited 1×
“However, BMI is still conventionally accepted as a measure of obesity (50).”
BackgroundWing, R. R., Lang, W., Wadden, T. A., Safford, M., Knowler, W. C., Bertoni, A. G., Hill, J. O., Brancati, F. L., Peters, A., Wagenknecht, L., et al. (2011) · Diabetes Care · doi:10.2337/dc10-2415 · Cited by 1,828 · cited 1×
“Obese patients with type 2 diabetes might not have diabetes if they lost weight (34).”
BackgroundFitting curves to data using nonlinear regression: a practical and nonmathematical review
Motulsky, H. J., & Ransnas, L. A. (1987) · The FASEB Journal · doi:10.1096/fasebj.1.5.3315805 · Cited by 1,327 · cited 1×
“The interaction between age (as a continuous variable) and BMI categories was also investigated using a logistic regression analysis (26, 27).”
MethodActive Smoking and the Risk of Type 2 Diabetes: A Systematic Review and Meta-analysis
Willi, C., Bodenmann, P., Ghali, W. A., Faris, P. D., & Cornuz, J. (2007) · JAMA · doi:10.1001/jama.298.22.2654 · Cited by 1,268
Pathophysiology of insulin resistance in human disease
Reaven, G. M. (1995) · Physiological Reviews · doi:10.1152/physrev.1995.75.3.473 · Cited by 1,226 · cited 1×
“Obesity, which promotes insulin resistance, may account for 80% of the population-attributable risk for type 2 diabetes (2).”
Background
Research works printed but not linked: 1
- 1995, World Health Organ Tech Rep Ser, 854, 1
Cited by
Items 101–200 of 201
Fröhlich, H., Bossmeyer, A., Kazmi, S., Goode, K. M., Agewall, S., Atar, D., Grundtvig, M., Frey, N., Cleland, J. G. F., Frankenstein, L., et al. (2023) · Clinical Research in Cardiology · doi:10.1007/s00392-023-02268-3 · Cited by 11
“Potential reasons for an increased mortality in lean patients include cachexia, frailty, reduced muscle mass and muscle strength, reduced metabolic reserve, and a greater burden of chronic disease and comorbidities [3, 8, 11, 37–40].”
BackgroundSelf-citationBilleter, A. T., Vittas, S., Israel, B., Scheurlen, K. M., Hidmark, Å. S., Fleming, T., Kopf, S., Büchler, M. W., & Müller-Stich, B. P. (2017) · Langenbeck s Archives of Surgery · doi:10.1007/s00423-017-1601-x · Cited by 13
“In contrast, there is an Bobesity paradox^ in that regard that obese patients with T2DM have a better longterm outcome than do non-severely obese patients with T2DM [30, 31].”
BackgroundWang, L., Du, X., Dong, J., Liu, W.-N., Zhou, Y., Li, S., Guo, X., Jiang, C., Yu, R., Sang, C., et al. (2019) · Clinical Research in Cardiology · doi:10.1007/s00392-019-01473-3 · Cited by 13
Nokihara, M., Fujihara, K., Yaguchi, Y., TAKIZAWA, H., KHIN, L. M., Ferreira, E. D. A., Sato, T., Horikawa, C., Kitazawa, M., Matsubayashi, Y., et al. (2025) · Diabetes Obesity and Metabolism · doi:10.1111/dom.16461 · Cited by 10
“12,13 Similarly, for macrovascular disease, reports identified positive, 14,15 inverse 16 or L-shaped associations 17 with obesity.”
Hu, T., Cai, R., Xu, Y., Wang, C., Shen, Y., Wu, L., Chen, L., Xia, T., & Bao, Y. (2026) · Cell Reports Medicine · doi:10.1016/j.xcrm.2025.102566 · Cited by 10
“…to identify BMI thresholds for this population have largely relied on single time point BMI measurement, 9,18–21 self-reported BMI data, 19 and cohorts predominantly comprising Western populations, 9,18–21 limiting their application to the Asian population, which accounts for 65% of global cases.”
Modifiable Risk Factors for Prevention in Dupuytren Disease: A UK Biobank Case-Control Study
Kang, Y., Stewart, M. E., Patel, M., Furniss, D., & Wiberg, A. (2023) · Plastic & Reconstructive Surgery · doi:10.1097/prs.0000000000010774 · Cited by 11
“36 Our data, in conjunction with this epidemiologic literature, highlight an important opportunity for diabetes prevention.”
ResultKong, G., Koh, J., Chia, J., Bryan, N. B. X., Chen, Y., Cao, G., Chong, B., Muthiah, M. D., Sim, H. W., Ng, G. Y. Q., et al. (2025) · Cardiovascular Diabetology · doi:10.1186/s12933-024-02552-0 · Cited by 10
“This is consistent with findings from several studies highlighting the increased risk of AMI or stroke in lean individuals with T2DM compared to their non-lean counterparts [49–52].”
Nutritive and Therapeutic Aspects of Whey Proteins
Lagrange, V., & Clark, D. C. (2018) · Elsevier eBooks · doi:10.1016/b978-0-12-812124-5.00016-3 · Cited by 13
Body mass index and stroke risk among patients with diabetes mellitus in Korea
Song, D. K., Hong, Y. S., Sung, Y., & Lee, H. (2022) · PLoS ONE · doi:10.1371/journal.pone.0275393 · Cited by 14
“In a prospective cohort study in England, which comprised 10,568 participants with type 2 DM and no known cardiovascular disease at baseline, over-weight or obese patients had a higher rate of cardiovascular events than those of normal weight [17].”
Time to redefine body mass index categories in chronic diseases? Spotlight on obesity paradox
Egom, E. E. A., Pharithi, R. B., Shiwani, H. A., Khan, B. U., Kružliak, P., Hiani, Y. E., & Maher, V. M. G. (2017) · International Journal of Food Sciences and Nutrition · doi:10.1080/09637486.2017.1389859 · Cited by 12
“Followed for 7.5 ± 4.5 years obesity was associated with a lower mortality risk in a clinical population of non-HF veterans Costanzo et al. (2015) Prospective cohort 10 568 patients with type 2 diabetes.”
BackgroundInfluentialLi, Y., Sheu, W. H., & Lee, I. (2020) · Diabetes Metabolic Syndrome and Obesity · doi:10.2147/dmso.s246032 · Cited by 11
Huang, H., Jin, J., Chen, Y., Wang, L., Zhong, J., Chen, Z., & Xu, L. (2022) · International Journal of Cardiology · doi:10.1016/j.ijcard.2022.08.033 · Cited by 10
Role of obesity in lower mortality risk in sepsis: a meta-analysis of observational studies
Lu, Y. (2024) · American Journal of Translational Research · doi:10.62347/uhbm7298 · Cited by 9
“This paradox has been extensively observed in cardiovascular diseases [9], cancers [10, 11], and metabolic disorders [12].”
BackgroundMehran, L., Honarvar, M., Masoumi, S., Khalili, D., Amouzegar, A., & Azizi, F. (2022) · Journal of Endocrinological Investigation · doi:10.1007/s40618-022-01881-9 · Cited by 10
“The term “obesity paradox” has been developed to justify the evidence indicating that being overweight or obese is linked to prolonged survival in those with diabetes or cardiovascular disease (CVD) [6, 7].”
BackgroundHu, J., Chen, X., Yang, J. J., Giovannucci, E. L., Lee, D. H., Luo, W., Cheng, Q., Gong, L., Wang, Z., Li, Q., et al. (2022) · Metabolism · doi:10.1016/j.metabol.2022.155307 · Cited by 9
Ahmad, H., Ahmed, Z., & Khan, R. (2016) · doi:10.12691/jfnr-4-8-8 · Cited by 9
“Obesity is one of the major risk factors for mortality among diabetics [32].”
BackgroundLeibovitz, E., Ben-David, N., Shibanov, L., Elias, S., & Shimonov, M. (2018) · Journal of Surgical Research · doi:10.1016/j.jss.2017.11.053 · Cited by 9
Kuo, C., Kuo, N.-R., Yeh, Y., Lee, Y., Chuang, L., Chen, H.-F., Chen, C., Lee, C., Hsu, C., Li, H., et al. (2024) · Lipids in Health and Disease · doi:10.1186/s12944-023-02001-z · Cited by 8
“The obesity paradox has also been reported to apply to patients with T2DM, possibly because genetically susceptible individuals develop T2DM at lower BMIs and have elevated risks of other diseases and complications, and thus poor prognoses [15, 16].”
Enders, D., Kollhorst, B., Engel, S., Linder, R., Verheyen, F., & Pigeot, I. (2016) · Journal of Diabetes and its Complications · doi:10.1016/j.jdiacomp.2016.05.015 · Cited by 10
Krittanawong, C., Tunhasiriwet, A., Wang, Z., Zhang, H., Prokop, L. J., Chirapongsathorn, S., Sun, T., Kitai, T., & Tang, W. H. W. (2018) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2017.12.021 · Cited by 9
López‐de‐Andrés, A., Jiménez‐García, R., Hernández‐Barrera, V., Jiménez‐Trujillo, I., Zamorano‐León, J. J., Carabantes-Alarcón, D., López‐Herránz, M., de Miguel-Yanes, J. M., & de Miguel‐Díez, J. (2021) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph18073659 · Cited by 8
“Several studies showed discordant results by reporting positive [50,51], inverse [52], and U-shaped associations [53] between obesity and diabetesrelated complications.”
Arslan, N., Akbulut, G., Süleymanoğlu, M., ALATAŞ, H., & Yaprak, B. (2022) · Nutrition & Food Science · doi:10.1108/nfs-06-2022-0177 · Cited by 9
García‐Rudolph, A., Kelleher, J. D., Cegarra, B., Saurí, J., Nedumpozhimana, V., Opisso, E., Tormos, J. M., & Bernabeu, M. (2021) · European Journal of Physical and Rehabilitation Medicine · doi:10.23736/s1973-9087.20.06411-4 · Cited by 9
Obesity paradox in cirrhosis: is it real or just an illusion?
Machado, M. V., & Cortez‐Pinto, H. (2016) · Liver International · doi:10.1111/liv.13154 · Cited by 8
“However, in some studies, only overweight, and not obesity, associated with better survival (6).”
BackgroundJose, A., Zhou, C., Baker, R., Walker, J., Kurek, N., O’Donnell, R. E., Elwing, J., & Gerson, M. C. (2021) · Journal of Nuclear Cardiology · doi:10.1007/s12350-021-02612-y · Cited by 9
The Paradox in Defining Obesity in Patients With Heart Failure
Kim, S.-E., & Lee, C. J. (2022) · International Journal of Heart Failure · doi:10.36628/ijhf.2022.0010 · Cited by 7
Wang, Y., Liu, X., Xue, T., Chen, Y., Yang, Q., Tang, Z., Chen, L., & Zhang, L. (2023) · Preventive Medicine Reports · doi:10.1016/j.pmedr.2023.102308 · Cited by 6
Association between obesity and 1-year mortality in septic patients: a retrospective cohort study
Zhang, L., Fang, L., Lihua, H., & Li, C. (2023) · BMJ Open · doi:10.1136/bmjopen-2022-066526 · Cited by 6
Timotin, A., Cinato, M., Boal, F., Dejean, S., Anesia, R., Arnaut, O., Lagente, C., Roncalli, J. G., Desmoulin, F., Tronchère, H., et al. (2018) · Scientific Reports · doi:10.1038/s41598-018-26118-9 · Cited by 7
Cui, W., Li, Y., Li, N., Chan, K. K., & Piao, C. (2025) · Endocrinology · doi:10.1210/endocr/bqaf040 · Cited by 5
Szwarcbard, N., Xiang, A., Gašević, D., JONES, A. M., Earnest, A., Andrikopoulos, S., Wischer, N., Sumithran, P., & Zoungas, S. (2025) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2025.112333 · Cited by 7
Scheen, A. J. (2025) · Expert Review of Clinical Pharmacology · doi:10.1080/17512433.2025.2527092 · Cited by 6
“Whereas the deleterious impact of obesity in younger patients with T2DM is obvious [2], this might be not so evident in older patients, especially after the description of a so-called ‘obesity paradox’ in the elderly population [102,103].”
El-Khoury, R., Mahfoud, Z. R., Dargham, S. R., Pal, M. A., Jayyousi, A., Suwaidi, J. M. S. A., & Khalil, C. A. (2025) · Biomedicines · doi:10.3390/biomedicines13123086 · Cited by 5
“In a large prospective cohort that included around 10,000 patients from the National Health Service, Costanzo et al. reported a lower risk of mortality in overweight patients with type 2 diabetes [24].”
The Control of Diabetes Mellitus in Coastal Communities in Surabaya Region
Yuliastuti, C., Arini, D., & Sari, M. P. E. (2019) · Jurnal Kesehatan Masyarakat · doi:10.15294/kemas.v15i1.16995 · Cited by 7
“A study by Costanzo et al. (2015) in 10568 diabetic patient for average 10.6 years showed that patients who were overweight or obese (BMI>25 kg/m2) had higher prevalence of cardiac disease (such as acute coronary syndrome and heart failure) compared to patients with normal BMI (18.5 to 24.9 kg/m2).”
BackgroundInfluentialBlackstone, R. P. (2016) · Springer eBooks · doi:10.1007/978-3-319-39409-1_5 · Cited by 8
Tsujimoto, T., & Kajio, H. (2019) · International Journal of Cardiology · doi:10.1016/j.ijcard.2019.02.008 · Cited by 5
Mortality after cardioverter-defibrillator replacement: Results of the DECODE survival score index
Zoni-Berisso, M., Martignani, C., Ammendola, E., Narducci, M. L., Caruso, D., Miracapillo, G., Notarstefano, P., Carinci, V., Pierantozzi, A., Ciaramitaro, G., et al. (2020) · Heart Rhythm · doi:10.1016/j.hrthm.2020.11.024 · Cited by 5
Dong, Y., Chen, Z., Gong, Y., Han, Y., Yu, H., Zeng, X., Chen, Z., An, R., Sun, N., & Yin, X. (2022) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgac485 · Cited by 5
Mirea, O., Oghli, M. G., Neagoe, O., Berceanu, M. C., Țieranu, E. N., Moraru, L., Raicea, V. C., & Donoiu, I. (2025) · Diabetology · doi:10.3390/diabetology6010005 · Cited by 6
“Although controversies are present in the literature [36,37], in our study, treatment with sulfonylureas showed a clear protective role for all-cause mortality.”
Lin, R., Yang, K., Guo, H., & Zhang, X. (2025) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2025.112016 · Cited by 5
Xu, R., Wang, C., Cong, H., & Wang, L. (2025) · Endocrine · doi:10.1007/s12020-025-04169-z · Cited by 4
“The “ obesity paradox ” is a phenomenon in which over-weight or mildly obese patients with cardiovascular disease exhibit lower mortality rates compared with those of normal weight, possibly due to the absence of signi fi cant metabolic abnormalities in a large subset of obese adults [14, 15].”
Duan, D., Li, H., Xu, J., Wong, L. P., Xu, G., Kong, F., Li, S., Gong, Q., Zhang, X., Zhao, J., et al. (2019) · Journal of Diabetes Research · doi:10.1155/2019/2591709 · Cited by 4
“Compared to subjects with shorter heights, subjects with taller heights were younger than their counterparts, and age is a well-known risk factor for IS [35].”
BackgroundLi, Y., Wang, C., Zhao, M., Yao, S., Wang, M., Zhang, S., Yun, C., Wu, S., & Xue, H. (2021) · The American Journal of the Medical Sciences · doi:10.1016/j.amjms.2021.02.014 · Cited by 5
Hong, J.-S., & Kang, H.-C. (2022) · BMJ Open · doi:10.1136/bmjopen-2021-048784 · Cited by 5
Nabrdalik, K., Bisson, A., Irlik, K., Fauchier, G., Ducluzeau, P., Lip, G. Y. H., & Fauchier, L. (2023) · Clinical Research in Cardiology · doi:10.1007/s00392-023-02344-8 · Cited by 4
“The obesity paradox may be present in patients with DM [9–13], but not all the studies have reported the same outcomes [14, 15].”
BackgroundMajeed, K., & Ali, H. (2026) · ASIDE Internal Medicine · doi:10.71079/aside.im.011626401 · Cited by 4
“Obesity contributes to IR, which is a significant factor in the development of T2D, potentially accounting for up to 80% of the risk associated with this condition [77].”
Obesity paradox in individuals with type 1 diabetes
Hamasaki, H. (2025) · Frontiers in Clinical Diabetes and Healthcare · doi:10.3389/fcdhc.2025.1670312 · Cited by 3
Modifiable risk factors of Alzheimer's disease and neuroinflammation: what are the links?
Bajwa, E., Pointer, C. B., & Klegeris, A. (2016) · Future Neurology · doi:10.2217/fnl-2016-0020 · Cited by 5
Baker, J. F., Ziolkowski, S., Long, J., Leonard, M. B., & Stokes, A. (2019) · The Journals of Gerontology Series A · doi:10.1093/gerona/glz144 · Cited by 3
Lee, D. G., Park, S., Kang, S. J., Kim, J. W., Lee, E. K., Song, C. H., Han, C.-H., Lee, Y. J., & Ku, S. (2016) · African Journal of Traditional Complementary and Alternative Medicines · doi:10.21010/ajtcam.v13i2.20 · Cited by 3
“Obesity contributes to the etiologies of various comorbid conditions, such as cardiovascular disease, hypertension and type 2 diabetes (Wendel et al., 2008; Costanzo et al., 2015).”
BackgroundBody mass index and mortality in patients with and without diabetes mellitus
Akirov, A., Shochat, T., Masri‐Iraqi, H., Dicker, D., Diker‐Cohen, T., & Shimon, I. (2017) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.2979 · Cited by 5
“Diabetes mellitus (DM) and obesity are closely related problems, as on one hand, obesity‐induced insulin resistance is a major contributor to type 2 DM and, on the other hand, various medical treatments for DM may lead to weight gain.(1,2)”
BackgroundKikuchi, H., Kanda, E., Mori, T., Sato, H., Iimori, S., Nomura, N., Naito, S., Sohara, E., Okado, T., Uchida, S., et al. (2018) · PLoS ONE · doi:10.1371/journal.pone.0208258 · Cited by 3
Kowall, B., Stang, A., Erbel, R., Moebus, S., Petersmann, A., Steveling, A., Jöckel, K., & Völzke, H. (2020) · Diabetes Metabolic Syndrome and Obesity · doi:10.2147/dmso.s242553 · Cited by 3
Does Rheumatoid Arthritis Cause an Obesity Paradox? Comment on the Article by Sparks et al
Baker, J. F., Kerr, G. S., & Mikuls, T. R. (2018) · Arthritis & Rheumatology · doi:10.1002/art.40412 · Cited by 3
Revisiting the Obesity Paradox in Health Care Expenditures Among Adults With Diabetes
Kumar, V., & Encinosa, W. E. (2022) · Clinical Diabetes · doi:10.2337/cd20-0122 · Cited by 2
Motofelea, A. C., Olariu, N., Pecingina, R., Marc, L., Chisavu, L. A., Bob, F. R., Mihăescu, A., Apostol, A., Schiller, O., Motofelea, N., et al. (2026) · Journal of Clinical Medicine · doi:10.3390/jcm15082856 · Cited by 2
High-sensitivity C-reactive protein as a prognostic marker in patients undergoing valve surgery
Duchnowski, P., Szymański, P., Kuśmierczyk, M., & Hryniewiecki, T. (2020) · Polish Journal of Cardio-Thoracic Surgery · doi:10.5114/kitp.2020.94185 · Cited by 2
“in extreme weight groups are at least partially characterized by systemic inflammation [15, 16].”
BackgroundOtsuka, K., Ishikawa, H., Shimada, K., Hojo, K., Yamaura, H., Kono, Y., Kasayuki, N., & Fukuda, D. (2023) · Reviews in Cardiovascular Medicine · doi:10.31083/j.rcm2412361 · Cited by 2
“This observation raises questions regarding the relationship be-tween BMI and ASCVD risk, which leads to the obesity paradox [3–5].”
BackgroundThe risks and benefits of managing obesity in older adults
Carroll, D. G. (2024) · American Journal of Health-System Pharmacy · doi:10.1093/ajhp/zxae288 · Cited by 2
Evolutionarily derived networks to inform disease pathways
Graham, B. E., Darabos, C., Huang, M., Muglia, L. J., Moore, J. H., & Williams, S. M. (2017) · Genetic Epidemiology · doi:10.1002/gepi.22078 · Cited by 2
“…identi-fied were also related to T2DM, including body mass index (Bays, Chapman, Grandy, & SHIELD Investigators’ Group, 2007), body weight and height (Costanzo et al., 2015), waist circumference (InterAct Consortium et al., 2012), high serum uric acid that is an independent risk factor for T2DM…”
BackgroundMa, J., Wang, X., Zheng, M., Yu, H., Ma, J., Li, X., Pan, J., & Huang, Y. (2019) · Endocrine Research · doi:10.1080/07435800.2019.1573826 · Cited by 2
“reported that overweight, and not obesity, was associated with a lower mortality risk.(10) Additionally, a study from China indicated that the risk for all-cause mortality was lower in overweight and obese groups than those in normal weight and underweight groups.”
BackgroundExplaining the obesity paradox in healthcare utilization among people with type 2 diabetes
Kumar, V., & Encinosa, W. E. (2021) · Diabetology International · doi:10.1007/s13340-021-00530-5 · Cited by 1
Ragab, H. M., Maksoud, N. A. E., Amin, M. A., & Elaziz, W. A. (2023) · Beni-Suef University Journal of Basic and Applied Sciences · doi:10.1186/s43088-023-00402-8 · Cited by 1
“(such as the acute coronary syndrome and heart failure) and other chronic diseases [22].”
BackgroundThe obesity paradox in patients with major burn injuries: a single tertiary burn centre review
Pollock, M., Paul, E. M., & Lo, C. H. (2024) · Australasian Journal of Plastic Surgery · doi:10.34239/ajops.90090 · Cited by 1
Guo, B., Yang, Y., Wang, N., Zhang, Y., Jiao, C., Wang, L., Yan, Y., & Fu, S. (2025) · Diabetology & Metabolic Syndrome · doi:10.1186/s13098-025-01848-9 · Cited by 1
“Furthermore, the “obesity paradox” in T2DM mortality suggests low BMI correlates with poorer outcomes, while overweight BMI may reduce mortality risk [12–14].”
Mo, H., Yan, Q., Wang, Y., Cheng, M., Yu, H., Sun, S., Wu, F., Li, Q., Yao, Z., Ge, H., et al. (2026) · BMC Geriatrics · doi:10.1186/s12877-026-07017-5 · Cited by 2
“…United Kingdom confirmed similar findings in 10,568 T2DM patients, showing that the overweight group (BMI 25 ~ 29.9) had a significantly lower mortality risk than the normal weight group, while the risk for the obese group (BMI > 30) did not significantly differ from the normal weight group [11].”
InfluentialEffects of different sugar-lipid ratio diets on the occurrence of type 2 diabetes mellitus
Sun, W., Jiang, L., Tang, S., An, X., Ji, H., & Lian, F. (2026) · Frontiers in Endocrinology · doi:10.3389/fendo.2026.1768263 · Cited by 1
“Clinically, T2DM manifests primarily as IR in early stages, progressing to pancreatic b -cell dysfunction (24).”
Kuri, K. A. C., Viola, V., & Pozzilli, P. (2026) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2026.113389 · Cited by 1
Can we reconcile ‘the obesity paradox’ with recent cardiovascular outcome trials in diabetes?
Jamieson, A., & Finer, N. (2017) · Clinical Obesity · doi:10.1111/cob.12217 · Cited by 2
“more likely to develop ‘at a lower BMI ‘stress’ (50), with greater risk for comorbidities and poor prognosis (48).”
BackgroundUnderstanding the Obesity Paradox in Type 2 Diabetes Mellitus
Costanzo, P., Lai, D.-B., & Atkin, S. L. (2015) · Current Cardiovascular Risk Reports · doi:10.1007/s12170-015-0461-6 · Cited by 2
Self-citationEmran, S. (2015) · UCL Discovery (University College London) · Cited by 1
Perez, M. J. (2015) · eScholarship (California Digital Library)
Abu-Wardeh, Y. S., Alsaqri, S., & AL-Nasr, T. (2016) · Journals & Books Hosting (International Knowledge Sharing Platform)
Resolving the KgA1c paradox in the management of type 2 diabetes mellitus
Davidson, J. A., Kalra, S., Singh, V., Fegade, M., Singh, G., & Mane, A. (2016) · Diabetes & Metabolic Syndrome Clinical Research & Reviews · doi:10.1016/j.dsx.2016.12.026
“A recent study in overweight or obese patients with T2DM, a higher rate of acute coronary syndrome, heart failure and increased likelihood of hospitalization due to cardiac events was observed in these patients than in patients with normal weight; further emphasizing the role of excess body weight leading to cardiovas…”
BackgroundEr overvekt gunstig ved diabetes?
Haugen, T. B. (2015) · Tidsskrift for Den norske legeforening · doi:10.4045/tidsskr.15.0615
Evaluación de barreras de autocuidado en Diabetes Mellitus tipo 2
Baustista, J. C. (2015) · LA Referencia (Red Federada de Repositorios Institucionales de Publicaciones Científicas)
A Nutrition Education Program for Advanced Practice Registered Nurses Caring for Obese Patients
Wilson, K. L. (2018) · ScholarWorks (Walden University)
Type 2 Diabetes in Offspring of Diabetic African American Women
Yak, T. V. (2016) · ScholarWorks (Walden University)
Kikuchi, K., Imaizumi, T., Ando, M., Kato, S., Kondo, T., Honda, H., Yoshida, Y., & Maruyama, S. (2020) · Internal Medicine · doi:10.2169/internalmedicine.5515-20
“Therefore, simple anthropometric obesity categorization does not necessarily contribute to the precise risk stratification, let alone “obesity paradox” issues (17-21).”
BackgroundYun, S.-B., & Kim, D. Y. (2021) · Journal of Animal Reproduciton and Biotechnology · doi:10.12750/jarb.36.4.203
“It has also been reported that it is still unclear whether weight loss can reduce the risk of death (Costanzo et al., 2015).”
BackgroundRagab, H. M., Maksoud, N. A. E., Amin, M. A., & Elaziz, W. A. (2023) · Research Square · doi:10.21203/rs.3.rs-2798448/v1
Furuya, T., Kitahama, S., Tamura, Y., Ogawa, S., Nakatani, Y., & Yasu, T. (2024) · Cureus · doi:10.7759/cureus.68561
“Although aging factors may also have influenced the decline in BMI and progression of atherosclerosis [20], there was no significant difference in age between the two groups divided by whether ba-PWV was above the age-specific reference value.”
BackgroundClinical Antiaging Medicine: Obesity, Metabolic Syndrome, and Antiaging Medicine
Masuzaki, H. (2024) · Springer eBooks · doi:10.1007/978-981-97-8514-8_68
Alyoshina, O. О., & Averyanova, I. V. (2025) · Siberian Journal of Life Sciences and Agriculture · doi:10.12731/2658-6649-2025-17-1-1047
Ferreira, J. P., Rossignol, P., Bakris, G., Mehta, C., White, W. B., & Zannad, F. M. (2021) · Figshare · doi:10.6084/m9.figshare.16621024
Al-Mhanna, S. B., Rocha‐Rodrigues, S., Mohamed, M., Batrakoulis, A., Aldhahi, M. I., Afolabi, H. A., Yagin, F. H., Alhussain, M. H., Gülü, M., Abubakar, B. D., et al. (2024) · Figshare · doi:10.6084/m9.figshare.26649351
Qiao, T., Luo, T., Pei, H., Yimingniyazi, B., Aili, D., Aimudula, A., Zhao, H., Zhang, H., Dai, J., & Wang, D. (2022) · Figshare · doi:10.6084/m9.figshare.21456014
Huber, M. B., Kurz, C., Kirsch, F. W., Schwarzkopf, L., Schramm, A., & Leidl, R. (2020) · Figshare · doi:10.6084/m9.figshare.13186152
KANEKO, M., Fujihara, K., Yamada, M. H., OSAWA, T., Yamamoto, M., Kitazawa, M., Matsubayashi, Y., Yamada, T., Seida, H., Kodama, S., et al. (2021) · Figshare · doi:10.6084/m9.figshare.14396571
Kuo, C.-S., Kuo, N.-R., Yeh, Y.-K., Lee, Y.-J., Chuang, L.-M., Chen, H.-F., Chen, C.-C., Lee, C.-C., Hsu, C.-C., Li, H.-Y., et al. (2024) · Figshare · doi:10.6084/m9.figshare.25052343
Kuo, C.-S., Kuo, N.-R., Yeh, Y.-K., Lee, Y.-J., Chuang, L.-M., Chen, H.-F., Chen, C.-C., Lee, C.-C., Hsu, C.-C., Li, H.-Y., et al. (2024) · Figshare · doi:10.6084/m9.figshare.25052462
Taieb, A. B., Roberts, E., Luckevich, M., Larsen, S., le Roux, C. W., de Freitas, P. G., & Wolfert, D. (2023) · Figshare · doi:10.6084/m9.figshare.22612829
Tazhibayeva, K., Abdrakhmanova, Z., Shensa, A., Raushanova, A., Sadykova, A., Glushkova, N., Mamyrbekova, S., Zhagiparova, Z., Beisbekova, A., & Linkov, F. Y. (2025) · PeerJ · doi:10.7717/peerj.20413
“…illness ( George et al., 2020 ), vaccination reduces hospitalization and mortality ( Kozhekenova et al., 2025 ), reinfections can follow a different clinical trajectory than primary cases ( Kassabekova et al., 2025 ), and obesity is a strong predictor of adverse prognosis ( Costanzo et al., 2015 ).”
Liu, H., Chen, Y., Yang, X., Pan, T., & Wang, S. (2026) · Metabolic Syndrome and Related Disorders · doi:10.1177/15578518261423748
“17 – 19 In contrast, CMI showed sharper discrimination in these subgroups.”
Kong, X., Xiao, N., Zhou, Q., Chen, Y., & Zhao, X. (2026) · Journal of International Medical Research · doi:10.1177/03000605261442794
Liu, Y., Fu, C., Li, F., Wang, H., & Zhu, M. (2026) · BMC Cardiovascular Disorders · doi:10.1186/s12872-026-06022-1
“Furthermore, mild overweight status in elderly people may provide essential metabolic reserves that protect against adverse health outcomes including frailty syndrome, nutritional deficiencies, and osteoporosis [32].”
Liu, Y., Liu, X., & Chen, B. (2026) · Medicine · doi:10.1097/md.0000000000049111
“[39,40] Alternatively, this pattern could reflect heterogeneity in HF pathophysiology, where diabetes-related myocardial dysfunction may involve pathways distinct from those involved in obesity-related remodeling.”
Chen, S. H., Chou, C., Weng, S., Chen, J., & Shen, F. (2026) · Journal of Diabetes Investigation · doi:10.1111/jdi.70379
“This fi nding is consistent with the ‘ obesity paradox ’ frequently reported in patients with chronic diseases 28, 29 .”
Masrouri, S., Hadaegh, P., Ebrahimi, N., Abdi, A., Azizi, F., & Hadaegh, F. (2026) · American Journal of Preventive Cardiology · doi:10.1016/j.ajpc.2026.101766
Somashekara, J., Ahamed, F., Pal, D., Palepu, S., Biswas, N., Roy, A., & Majhi, J. (2026) · Indian Journal of Community Medicine · doi:10.4103/ijcm.ijcm_1_26
“[27,28] This reverse J-shaped BMI– glycemic control relationship has been observed across Asian cohorts.”
Metadata
- Authors
- Costanzo, P., Cleland, J. G. F., Pellicori, P., Clark, A. L., Hepburn, D., Kilpatrick, E. S., Perrone-Filardi, P., Zhang, J., & Atkin, S. L.
- Affiliations
- University of Hull (GB)
- From Hull York Medical School, University of Hull, Kingston upon Hull, United Kingdom; Castle Hill Hospital, Cottingham, United Kingdom; National Heart & Lung Institute, Imperial College, London, United Kingdom; and Federico II University, Naples, Italy.
- ORCID
- Venue
- Annals of Internal Medicine
- Publisher
- American College of Physicians
- Published
- 2015-05-05
- Volume
- 162
- Issue
- 9
- Pages
- 610-618
- ISSN
- 0003-4819 (ISSN-L)
- 1539-3704
- OpenAlex
- W1488210487
- Cited by
- 199
- References
- 49
- Citations by year
- 2026: 14 · 2025: 17 · 2024: 14 · 2023: 16 · 2022: 15 · 2021: 18 · 2020: 20 · 2019: 14 · 2018: 20 · 2017: 16 · 2016: 30 · 2015: 5
- FWCI
- 20.52
- Type
- journal article
- Language
- en
- Open access
- green
- figshare.com
- Licence
- cc-by
- Locations
- Annals of Internal Medicine (publishedVersion)
- PubMed (publishedVersion)
- Anglia Ruskin Research Online (Anglia Ruskin University) (submittedVersion)
- ENLIGHTEN (Jurnal Bimbingan dan Konseling Islam) (submittedVersion)
- Figshare (submittedVersion, cc-by)
- Repository@Hull (Worktribe) (University of Hull) (submittedVersion, cc-by)
- Annals of Internal Medicine
- Funders
- National Institute for Health and Care Research (NF-SI-0611-10227)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Treatment and Management
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiovascular Function and Risk Factors
- Keywords
- obesity paradox, type 2 diabetes, body mass index, overweight, obesity, prognosis, all-cause mortality, cardiovascular morbidity, acute coronary syndrome, heart failure, stroke, underweight
- MeSH terms
- Aged, Cardiovascular Diseases, Cause of Death, Diabetes Mellitus, Type 2, Female, United Kingdom, Humans, Longitudinal Studies, Male, Middle Aged, Obesity, Prognosis, Prospective Studies, Risk Factors, Body Mass Index, Proportional Hazards Models, Overweight, Kaplan-Meier Estimate
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.